QT
ALXN

Quantbot Technologies’s Alexion Pharmaceuticals ALXN Stock Holding History

Quantbot Technologies’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-3,471
Closed -$530K – 2044
2021
Q1 		$530K Sell
3,471
-5,284
-60% -$817K 0.05% 473
2020
Q4 		$1.37M Buy
+8,755
New +$1.13M 0.14% 197
2020
Q3 		– Sell
-11,955
Closed -$1.34M – 1765
2020
Q2 		$1.34M Buy
+11,955
New +$1.27M 0.18% 148
2020
Q1 		– Sell
-1,417
Closed -$153K – 1577
2019
Q4 		$153K Sell
1,417
-19,922
-93% -$2.13M 0.02% 720
2019
Q3 		$2.09M Sell
21,339
-12,084
-36% -$1.36M 0.21% 135
2019
Q2 		$4.38M Buy
+33,423
New +$4.31M 0.44% 61
2019
Q1 		– Sell
-24,951
Closed -$2.43M – 1376
2018
Q4 		$2.43M Buy
24,951
+14,642
+142% +$1.73M 0.24% 124
2018
Q3 		$1.43M Buy
10,309
+7,091
+220% +$890K 0.1% 289
2018
Q2 		$399K Sell
3,218
-9,546
-75% -$1.12M 0.03% 628
2018
Q1 		$1.42M Buy
+12,764
New +$1.53M 0.12% 231
2017
Q4 		– Sell
-1,361
Closed -$190K – 1580
2017
Q3 		$190K Sell
1,361
-8,790
-87% -$1.19M 0.02% 719
2017
Q2 		$1.24M Buy
+10,151
New +$1.18M 0.12% 224
2016
Q4 		– Sell
-9,130
Closed -$1.12M – 1448
2016
Q3 		$1.12M Sell
9,130
-40,641
-82% -$5.23M 0.12% 201
2016
Q2 		$5.81M Buy
+49,771
New +$7.06M 0.62% 31
2015
Q4 		– Sell
-20,734
Closed -$3.24M – 1484
2015
Q3 		$3.24M Buy
20,734
+19,951
+2,548% +$3.64M 0.57% 34
2015
Q2 		$141K Sell
783
-7,109
-90% -$1.23M 0.03% 539
2015
Q1 		$1.37M Buy
+7,892
New +$1.43M 0.34% 73
2014
Q2 		– Sell
-400
Closed -$60K – 1463
2014
Q1 		$60K Buy
+400
New +$63.6K 0.01% 734

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Quantbot Technologies's ALXN Position: Q2 2021 in Review

Quantbot Technologies sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 3,471 shares — an estimated $530K sold.

Quantbot Technologies first reported a position in ALXN in Q1 2014 and held it in 18 quarters. The position peaked at $5.81M in Q2 2016. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Quantbot Technologies reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantbot Technologies sold 3,471 Alexion Pharmaceuticals shares in Q2 2021, an estimated $530K.
  • Quantbot Technologies first reported a position in Alexion Pharmaceuticals in Q1 2014 and held it in 18 quarters.
  • Quantbot Technologies's Alexion Pharmaceuticals position peaked at $5.81M in Q2 2016.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Quantbot Technologies's 13F filing for Q2 2021, filed 12 Aug 2021.